Actinomycin D for fibrosis management in ophthalmic implant surgery
Implants that feature a drug delivery system loaded with antifibrotic active drugs provide a promising approach to address postoperative complications caused by fibrosis. This study is intended to clarify whether Actinomycin D has an impact specifically on components of the extracellular matrix (ECM...
Збережено в:
| Автори: | , , , , , , |
|---|---|
| Формат: | Artigo |
| Мова: | Inglês |
| Опубліковано: |
De Gruyter
2019-09-01
|
| Серія: | Current Directions in Biomedical Engineering |
| Предмети: | |
| Онлайн доступ: | https://doi.org/10.1515/cdbme-2019-0121 |
| Теги: |
Немає тегів, Будьте першим, хто поставить тег для цього запису!
|